Stelara 90MG/ML SYR 1S
Ended Awarded
- Contract number
- SPE2DX25FKWAS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $32,500
Award facts
- Contract value 100% obligated
- $32,499.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 for STELARA 90MG/ML syringes on September 16, 2025. The delivery order, which carries no set-aside designation, is funded by the Defense Logistics Agency's Medical Supply Chain division and is set for ultimate completion by September 30, 2025. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities worldwide.
STELARA is a biologic immunosuppressant medication commonly used to treat autoimmune conditions such as psoriasis, psoriatic arthritis, and Crohn's disease. This delivery order represents a routine procurement of the pharmaceutical product to support the medical supply needs of military health facilities. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical distribution network, leveraging its status as a registered small business to consistently compete for and secure contracts with federal agencies. The company's extensive contract portfolio demonstrates its capability to reliably deliver specialized pharmaceutical products, including biologics and branded medications, directly to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DX25FKWAS?
SPE2DX25FKWAS was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 16, 2025.
How much is contract SPE2DX25FKWAS worth?
The government has obligated $32,500 on SPE2DX25FKWAS.
Is contract SPE2DX25FKWAS an order under another contract?
Yes. SPE2DX25FKWAS is a delivery order under SPE2DX15D9628, an indefinite delivery contract.
Was contract SPE2DX25FKWAS competed?
The extent of competition for SPE2DX25FKWAS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award